IT:RDHL Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.This company has ADRs that trade in the U.S. as the symbol RDHL.

170.00 ILS
As of 02/11/2020

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  01/01/1900
Stock exchange:    Tel Aviv Stock Exchange
Exchange country:   Israel
Market cap:   599,583,232 ILS
Current dividend yield:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy